Search for content, post, videos

NeuroVive conducts a directed new share issue of SEK 5.3 million

The company is conducting a directed new issue of shares, which is expected to add close to SEK 5.3 million to NeuroVive. Proceeds from the new share issue will be used primarily for continued clinical development of KL1333 and NeuroSTAT. NeuroVive's Board of Directors has decided to conduct
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.